| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $57.41 | $2,275,420.44 | -0.4% | |
| Feb 8, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 48,180 | $56.47 | $2,720,677.46 | -0.4% | |
| Feb 7, 2019 | Schoeneck James A47 | Director | Sale+OE | 2,000 | $57.17 | $114,340.00 | -6.7% | |
| Jan 23, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 60,000 | $52.00 | $3,120,142.14 | -0.5% | |
| Jan 7, 2019 | Schoeneck James A47 | Director | Sale+OE | 2,000 | $45.90 | $91,800.00 | -6.7% | |
| Jan 4, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 60,000 | $44.39 | $2,663,480.04 | -0.4% | |
| Dec 20, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $41.00 | $41,000.00 | -3.0% | |
| Dec 19, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $41.32 | $165,288.00 | -7.4% | |
| Dec 18, 2018 | Cotroneo Pat | SVP, Finance And CFO | Sell | 3,330 | $41.10 | $136,863.00 | -1.5% | |
| Dec 14, 2018 | Yu K Peony | Chief Medical Officer | Sell | 3,422 | $38.58 | $132,020.76 | -2.3% |